Po‐Nan Wang

Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial

Harry P. Erba, Pau Montesinos, Hee‐Je Kim et al. · The Lancet · 2023 · 319 citations

Hematological Malignancy, Medicine, Hematology +5

Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse

Lee‐Yung Shih, Chein‐Fuang Huang, Jin‐Hou Wu et al. · Blood · 2002 · 286 citations

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 231 citations · Full text

Regenerative Medicine, Cell Therapy, Transplantation +7

Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia

Hung Chang, Ming‐Chung Kuo, Lee‐Yung Shih et al. · European Journal Of Haematology · 2011 · 114 citations

Internal tandem duplication and Asp835 mutations of the <i>FMS‐</i>like tyrosine kinase 3 (<i>FLT3</i>) gene in acute promyelocytic leukemia

Lee‐Yung Shih, Ming‐Chung Kuo, Der‐Cherng Liang et al. · Cancer · 2003 · 79 citations · Full text